[How many leads are needed for an ICD?].

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Context:

• The use of implantable cardioverter defibrillators (ICDs) is expanding beyond secondary prevention to include primary prevention of sudden cardiac death (SCD).
• Key clinical trials like MADIT II, Companion, and SCD-HeFT support the use of ICDs for primary SCD prevention.
• Reduced left ventricular ejection fraction (LVEF ≤ 35%) is a primary risk factor for SCD.

Purpose:

• To outline the criteria for selecting appropriate implantable cardioverter defibrillator (ICD) devices and lead configurations for sudden cardiac death (SCD) prevention.
• To guide clinicians in choosing the optimal ICD therapy based on patient-specific clinical parameters.

Summary:

• For primary prevention of SCD, a single-lead VVI ICD is often sufficient, particularly when LVEF is reduced.
• Biventricular ICD devices are preferred for patients with AV conduction delay, symptomatic heart failure, and prolonged QRS duration, facilitating ventricular resynchronization.
• Dual-chamber devices are best reserved for sinus nodal disease and situations requiring enhanced discrimination of slow ventricular tachycardias.

Impact:

• Optimizing ICD selection can improve patient outcomes and reduce the incidence of sudden cardiac death.
• Tailoring device choice to individual patient profiles ensures effective therapy and appropriate resource utilization.
• This approach enhances the management of heart failure patients at risk for SCD.